Philips Expands Benelux Home Healthcare Offering

PhilipsRoyal Philips (NYSE: PHG, AEX: PHIA) is expanding its focus on home healthcare with an innovative home medication dispensing service designed to support chronically ill patients and care providers. The new service provides automated, compact dispensers loaded with personalized pre-packaged medication and features a dedicated web-based IT connection to the patient's care giver organization and pharmacist. Building on its broad portfolio of home health care capabilities Philips, is now rolling out its new service in the Netherlands, Belgium and Luxembourg (Benelux). With the new service, Philips is expanding its home healthcare activities in the Benelux to home care, elderly care and nursing home organizations.

By offering the prescribed medication at the preprogrammed time, as well as monitoring and support, the service aims to increase medication adherence among seniors and chronically ill patients. This could improve their health and quality of life, while reducing avoidable hospital stays, adverse events and healthcare costs, and supporting healthcare organizations.

Each time medication is due, the dispenser automatically reminds the person, checks it is the right medication at the right time and then releases and opens individual pouches according to the patient’s prescribed regimen. This motivates the patient to adhere to personal medication plans and minimizes the risk of taking the wrong medication or dose. The solution monitors medication usage and remotely alerts nursing staff when medication is not taken, helping to streamline the normally time-consuming task of medication management and allowing them to focus on additional care issues.

"Technology-enabled care at home will play an increasingly important role in helping care providers cope with the pressing challenges presented by rising numbers of people with chronic conditions," said Henk Valk, General Manager Philips Healthcare Benelux. "For more than a decade, Philips has been a pioneer in the home healthcare market in the Netherlands, and we are continuously looking to expand our offering through collaborations, innovative technologies and services that can make a difference where it matters for patients, their families and healthcare providers."

"Poor medication adherence is relatively common and has dramatic effects on individual and population-level health," said Dick Herfst, CEO of ZZG zorggroep, a Dutch home care, elderly care and nursing home organization that is already using the initial version of the service. "Helping clients take their medication correctly and in time is an important, but often time-consuming task for our community nurses. With the help of this medication dispensing service, we see clients are more compliant and independent while their relatives feel more comfortable."

As people live longer, chronic illness is increasingly common and places a growing burden on healthcare systems. Home healthcare provides new cost effective ways to support seniors and chronically ill patients while retaining an independent lifestyle. Studies show that around 50% of medication for chronic disease is not taken as prescribed [1]. Each year in the Netherlands, 19.000 potentially avoidable hospitalizations involve elderly people who took their medication incorrectly, adding up to an annual financial burden of EUR 85 million [2].

The home medication dispensing service for the Benelux differs from the medication dispensing service that Philips already offers in the United States, as it is based on a medication pouches system that is standardized and broadly available in the Netherlands. To bring the solution to market in the Netherlands, Philips is collaborating with the Dutch pharmaceutical telehealth company Innospense, that initially developed the integrated medication dispensing service, and is assisted by e-health implementation provider Focus Cura. Philips will also work with pharmacies to ensure the patient’s prescribed regimen is synchronized with the intelligent dispensing device in the patient's home.

Related news articles:

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2012 sales of EUR 24.8 billion and employs approximately 114,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

1. Closing the Quality Gap Series: Medication Adherence Interventions: Comparative Effectiveness Hospitals Admissions
2. Related to Medication (HARM study), Division of Pharmacoepidemiology & Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, 2006

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...